Skip to contentGREENLEAF DANIEL E — BioScrip, Inc. insider: 56 transactions · InsiderLensGREENLEAF DANIEL E
- Director at VioQuest Pharmaceuticals, Inc. · on record since Apr 6, 2006
- President and CEO at VioQuest Pharmaceuticals, Inc. · on record since Apr 6, 2006
- President, Coram Infusion Div. at APRIA HEALTHCARE GROUP INC · on record since Apr 9, 2008
- Chief Executive Officer at BioScrip, Inc. · on record since Sep 23, 2016
- Director at PROVIDENCE SERVICE CORP · on record since Dec 13, 2019
- CEO and President at PROVIDENCE SERVICE CORP · on record since Dec 13, 2019
Insider trading activity of GREENLEAF DANIEL E
- Transactions on record
- 56
- since Feb 14, 2005
- Open-market buys
- 16
- $180.9K
- Open-market sells
- 0
- Companies traded
- 4
- last filing Feb 10, 2022
Figures computed from official regulatory filings — methodology.
Companies where GREENLEAF DANIEL E has traded
Track record of GREENLEAF DANIEL E
Statistical track record
Free- Open-market buys
- 18
- Last buy
- Sep 15, 2021
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of GREENLEAF DANIEL E
Co-insiders of GREENLEAF DANIEL E
- Coliseum Capital, LLCBioScrip, Inc. +1
- Coliseum Capital Management, LLCBioScrip, Inc. +1
- Coliseum Capital Partners II, L.P.BioScrip, Inc. +1
- COLISEUM CAPITAL PARTNERS L PBioScrip, Inc. +1
- Gray AdamBioScrip, Inc. +1
- MCMAHON JOHNBioScrip, Inc. +1
- Pate R CarterBioScrip, Inc. +1
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Shackelton Christopher SBioScrip, Inc. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Feb 10, 2022 | AwardD | 26,136 | 0.00 USD | $0 | SEC |
| Feb 10, 2022 | Award | 9,170 | 0.00 USD | $0 | SEC |
| Feb 10, 2022 | AwardD | 18,340 | 0.00 USD | $0 | SEC |
| Sep 17, 2021 | Buy | 581 | 172.85 USD | $100.4K | SEC |
| Apr 12, 2021 | AwardD | 15,491 | 0.00 USD | $0 | SEC |
| Feb 17, 2021 | Other | -1,179 | 178.53 USD | $210.5K | SEC |
| Feb 12, 2021 | Award | 4,742 | 0.00 USD | $0 | SEC |
| Feb 12, 2021 | AwardD | 16,595 | 0.00 USD | $0 | SEC |
| Dec 15, 2020 | Other | -1,457 | 142.97 USD | $208.3K | SEC |
| Feb 18, 2020 | AwardD | 45,119 | 0.00 USD | $0 | SEC |
| Feb 18, 2020 | Award | 12,287 | 0.00 USD | $0 | SEC |
| Dec 13, 2019 | Award | 20,104 | 0.00 USD | $0 | SEC |
| Dec 13, 2019 | AwardD | 40,432 | 0.00 USD | $0 | SEC |
| Dec 13, 2019 | AwardD | 67,090 | 0.00 USD | $0 | SEC |
| May 20, 2019 | Other | -62,734 | 2.00 USD | $125.5K | SEC |
| May 20, 2019 | ExerciseD | -197,727 | 0.00 USD | $0 | SEC |
| May 20, 2019 | Exercise | 197,727 | 0.00 USD | $0 | SEC |
| Apr 22, 2019 | Other | -67,994 | 1.82 USD | $123.7K | SEC |
| Apr 22, 2019 | ExerciseD | -98,425 | — | — | SEC |
| Apr 22, 2019 | Exercise | 136,185 | 0.00 USD | $0 | SEC |
| Apr 22, 2019 | ExerciseD | -136,185 | — | — | SEC |
| Apr 22, 2019 | Exercise | 98,425 | 0.00 USD | $0 | SEC |
| Feb 12, 2019 | ExerciseD | -64,350 | — | — | SEC |
| Feb 12, 2019 | Exercise | 64,350 | 0.00 USD | $0 | SEC |
| Feb 12, 2019 | Other | -21,654 | 3.59 USD | $77.7K | SEC |